Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Alzheimer's Disease

  Free Subscription


Articles published in Alzheimer Dis Assoc Disord

Retrieve available abstracts of 103 articles:
HTML format



Single Articles


    August 2021
  1. EZZATI A, Zammit AR, Lipton RB
    Comparing Performance of Different Predictive Models in Estimating Disease Progression in Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2021 Aug 16. pii: 00002093-900000000-99219.
    PubMed     Abstract available


    July 2021
  2. WANG T, Guo Z, Du Y, Xiong M, et al
    Effects of Noninvasive Brain Stimulation (NIBS) on Cognitive Impairment in Mild Cognitive Impairment and Alzheimer Disease: A Meta-analysis.
    Alzheimer Dis Assoc Disord. 2021;35:278-288.
    PubMed     Abstract available


    May 2021
  3. LI XY, Cui Y, Jing D, Xie K, et al
    Novel PSEN1 and PSEN2 Mutations Identified in Sporadic Early-onset Alzheimer Disease and Posterior Cortical Atrophy.
    Alzheimer Dis Assoc Disord. 2021 May 11. pii: 00002093-900000000-99233.
    PubMed     Abstract available


  4. SYKORA D, Stonnington CM, Jain N
    An Agitated Patient With COVID-19 Infection and Early-onset Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2021 May 11. pii: 00002093-900000000-99231.
    PubMed     Abstract available


    April 2021
  5. LOIZOS M, Neugroschl J, Zhu CW, Li C, et al
    Adapting Alzheimer Disease and Related Dementias Clinical Research Evaluations in the Age of COVID-19.
    Alzheimer Dis Assoc Disord. 2021 Apr 26. pii: 00002093-900000000-99236.
    PubMed     Abstract available


    March 2021
  6. ERYILMAZ IE, Bakar M, Egeli U, Cecener G, et al
    Evaluation of the Clinical Features Accompanied by the Gene Mutations: The 2 Novel PSEN1 Variants in a Turkish Early-onset Alzheimer Disease Cohort.
    Alzheimer Dis Assoc Disord. 2021 Mar 24. pii: 00002093-900000000-99239.
    PubMed     Abstract available


  7. AL-THANI HF, Ahmad MN, Younes S, Zayed H, et al
    Genetic Variants Associated With Alzheimer Disease in the 22 Arab Countries: A Systematic Review.
    Alzheimer Dis Assoc Disord. 2021 Mar 23. pii: 00002093-900000000-99240.
    PubMed     Abstract available


    January 2021
  8. GARCIA-MEJIA KA, Custodio-Chable SJ, Vazquez-Franco JE, Reyes-Maldonado E, et al
    beta-Amyloid Orchestrates Factor XII and Platelet Activation Leading to Endothelial Dysfunction and Abnormal Fibrinolysis in Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2021 Jan 27. pii: 00002093-900000000-99250.
    PubMed     Abstract available


  9. RINGMAN JM, Joe E, Sheikh-Bahaei N, Miller C, et al
    Cerebral Amyloid Angiopathy-related Inflammation Presenting With a Cystic Lesion in Young-onset Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2021 Jan 20. pii: 00002093-900000000-99251.
    PubMed     Abstract available


  10. GIANNOULI V, Tsolaki M
    Mild Alzheimer Disease, Financial Capacity, and the Role of Depression: Eyes Wide Shut?
    Alzheimer Dis Assoc Disord. 2021 Jan 11. pii: 00002093-900000000-99254.
    PubMed     Abstract available


  11. GARCIA-MEJIA KA, Custodio-Chable SJ, Vazquez-Franco JE, Reyes-Maldonado E, et al
    beta-Amyloid Orchestrates Factor XII and Platelet Activation Leading to Endothelial Dysfunction and Abnormal Fibrinolysis in Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2021;35:91-97.
    PubMed     Abstract available


    December 2020
  12. MURATA S, Ono R, Sugimoto T, Toba K, et al
    Functional Decline and Body Composition Change in Older Adults With Alzheimer Disease: A Retrospective Cohort Study at a Japanese Memory Clinic.
    Alzheimer Dis Assoc Disord. 2020 Dec 14. doi: 10.1097/WAD.0000000000000426.
    PubMed     Abstract available


  13. BARDACH SH, Langbaum JB, Kebodeaux CS, Jicha GA, et al
    Real-world Site Experiences With GeneMatch: The Role of a Recruitment-related Registry in the Context of Local Site Effort to Support Alzheimer Disease Prevention Research.
    Alzheimer Dis Assoc Disord. 2020 Dec 2. doi: 10.1097/WAD.0000000000000425.
    PubMed     Abstract available


    October 2020
  14. RYAN MM, Cox CG, Witbracht M, Hoang D, et al
    Using Direct-to-Consumer Genetic Testing Results to Accelerate Alzheimer Disease Clinical Trial Recruitment.
    Alzheimer Dis Assoc Disord. 2020 Oct 14. doi: 10.1097/WAD.0000000000000421.
    PubMed     Abstract available


  15. FUNNELL C, Feldman HH, Mackenzie IRA, DeMarco ML, et al
    Applying the Alzheimer Disease ATN Diagnostic Framework in Atypical Dementia.
    Alzheimer Dis Assoc Disord. 2020;34:357-359.
    PubMed     Abstract available


    September 2020
  16. GOMEZ-GALLEGO M, Gallego-Mellado M, Gomez-Gallego JC, Gomez-Garcia JG, et al
    Sex Moderates the Relationship of Stress and Perceived Social Support With Neuropsychological Symptoms Among Community-dwelling Persons With Alzheimer Disease in Spain.
    Alzheimer Dis Assoc Disord. 2020 Sep 30. doi: 10.1097/WAD.0000000000000416.
    PubMed     Abstract available


  17. HENG LC, Lim SH, Foo H, Kandiah N, et al
    Confluent White Matter in Progression to Alzheimer Dementia.
    Alzheimer Dis Assoc Disord. 2020 Sep 30. doi: 10.1097/WAD.0000000000000409.
    PubMed     Abstract available


  18. BARDACH SH, Kent S, Jicha GA
    Alzheimer Disease Worries, Fears, and Stigma and Their Relationship to Genetic and Interventional Research Engagement.
    Alzheimer Dis Assoc Disord. 2020 Sep 21. doi: 10.1097/WAD.0000000000000413.
    PubMed     Abstract available


  19. KISELICA AM, Kaser AN, Benge JF
    An Initial Empirical Operationalization of the Earliest Stages of the Alzheimer's Continuum.
    Alzheimer Dis Assoc Disord. 2020 Sep 21. doi: 10.1097/WAD.0000000000000408.
    PubMed     Abstract available


  20. YANG D, Masurkar AV
    Clinical Profiles of Arteriolosclerosis and Alzheimer Disease at Mild Cognitive Impairment and Mild Dementia in a National Neuropathology Cohort.
    Alzheimer Dis Assoc Disord. 2020 Sep 11. doi: 10.1097/WAD.0000000000000411.
    PubMed     Abstract available


    August 2020
  21. ZHU CW, Lee S, Ornstein KA, Cosentino S, et al
    Dependence Clusters in Alzheimer Disease and Medicare Expenditures: A Longitudinal Analysis From the Predictors Study.
    Alzheimer Dis Assoc Disord. 2020 Aug 19. doi: 10.1097/WAD.0000000000000402.
    PubMed     Abstract available


    July 2020
  22. SCHIPKE CG, Menne F, Rubow S, Sigle JP, et al
    Value of a Panel of 6 Serum Biomarkers to Differentiate between Healthy Controls and Mild Cognitive Impairment Due to Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2020 Jul 7. doi: 10.1097/WAD.0000000000000397.
    PubMed     Abstract available


    June 2020
  23. MOULIN MARES SRA, Groner JS, de Oliveira MP, Lirio LV, et al
    Takotsubo Cardiomyopathy in an Alzheimer Disease Patient: The Potential Contribution of Antidepressant Agents.
    Alzheimer Dis Assoc Disord. 2020 Jun 9. doi: 10.1097/WAD.0000000000000395.
    PubMed     Abstract available


  24. STOJANOVIC M, Jin Y, Fagan AM, Benzinger TL, et al
    Physical Exercise and Longitudinal Trajectories in Alzheimer Disease Biomarkers and Cognitive Functioning.
    Alzheimer Dis Assoc Disord. 2020 Jun 9. doi: 10.1097/WAD.0000000000000385.
    PubMed     Abstract available


    May 2020
  25. SACHS BC, Steenland K, Zhao L, Hughes TM, et al
    Expanded Demographic Norms for Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set.
    Alzheimer Dis Assoc Disord. 2020 May 29. doi: 10.1097/WAD.0000000000000388.
    PubMed     Abstract available


  26. GANDHI P, Klatt BN, Agrawal Y
    Physical and Vestibular Physical Therapy Referrals in People With Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2020 May 27. doi: 10.1097/WAD.0000000000000390.
    PubMed     Abstract available


  27. KITAMURA J, Nagai M, Ueno H, Ohshita T, et al
    The Insular Cortex, Alzheimer Disease Pathology, and Their Effects on Blood Pressure Variability.
    Alzheimer Dis Assoc Disord. 2020 May 6. doi: 10.1097/WAD.0000000000000340.
    PubMed     Abstract available


    April 2020
  28. MOCK C, Teylan M, Beecham G, Besser L, et al
    The Utility of the National Alzheimer's Coordinating Center's Database for the Rapid Assessment of Evolving Neuropathologic Conditions.
    Alzheimer Dis Assoc Disord. 2020 Apr 16. doi: 10.1097/WAD.0000000000000380.
    PubMed     Abstract available


    March 2020
  29. MONTOYA Y, Balbim GM, Glover CM, Marquez DX, et al
    "My Parent's Body Is Sacred": Perspectives From Adult Latino Children About Brain Donation for Alzheimer Disease Research.
    Alzheimer Dis Assoc Disord. 2020 Mar 24. doi: 10.1097/WAD.0000000000000377.
    PubMed     Abstract available


    February 2020
  30. BERKES M, Bialystok E, Craik FIM, Troyer A, et al
    Conversion of Mild Cognitive Impairment to Alzheimer Disease in Monolingual and Bilingual Patients.
    Alzheimer Dis Assoc Disord. 2020 Feb 13. doi: 10.1097/WAD.0000000000000373.
    PubMed     Abstract available


    January 2020
  31. SHERZAI AZ, Parasram M, Haider JM, Sherzai D, et al
    Alzheimer Disease and Cancer: A National Inpatient Sample Analysis.
    Alzheimer Dis Assoc Disord. 2020 Jan 27. doi: 10.1097/WAD.0000000000000369.
    PubMed     Abstract available


  32. JOUNG KI, Shin JY, Kim S, Cho SI, et al
    Anticholinergic Use Among the Elderly With Alzheimer Disease in South Korea: A Population-based Study.
    Alzheimer Dis Assoc Disord. 2020 Jan 7. doi: 10.1097/WAD.0000000000000370.
    PubMed     Abstract available


  33. EL HAJ M, Boutoleau-Bretonniere C, Gallouj K
    The Past as Seen by Women and Men With Alzheimer Disease: Sex Differences in Autobiographical Memory.
    Alzheimer Dis Assoc Disord. 2020 Jan 7. doi: 10.1097/WAD.0000000000000363.
    PubMed     Abstract available


  34. NG KP, Wong B, Xie W, Kandiah N, et al
    Capgras Syndrome in the Young: Schizophrenia or Alzheimer Disease?
    Alzheimer Dis Assoc Disord. 2020 Jan 7. doi: 10.1097/WAD.0000000000000360.
    PubMed     Abstract available


  35. BARRETT B, Schultz SK, Luther SL, Friedman Y, et al
    Mortality and Associated Risk Factors in Community-Dwelling Persons With Early Dementia.
    Alzheimer Dis Assoc Disord. 2020;34:40-46.
    PubMed     Abstract available


    October 2019
  36. LO TWB, Karameh WK, Barfett JJ, Fornazzari LR, et al
    Association Between Neuropsychiatric Symptom Trajectory and Conversion to Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2019 Oct 15. doi: 10.1097/WAD.0000000000000356.
    PubMed     Abstract available


    September 2019
  37. GRILL JD, Kwon J, Teylan MA, Pierce A, et al
    Retention of Alzheimer Disease Research Participants.
    Alzheimer Dis Assoc Disord. 2019 Sep 26. doi: 10.1097/WAD.0000000000000353.
    PubMed     Abstract available


  38. BOEDEKER S, Schulz P, Beblo T, Lenz E, et al
    Symbol Comprehension in Patients With Alzheimer Disease Dementia, Mild Cognitive Impairment, and Major Depressive Disorder.
    Alzheimer Dis Assoc Disord. 2019 Sep 19. doi: 10.1097/WAD.0000000000000347.
    PubMed     Abstract available


    August 2019
  39. HAZEN J, Vistnes M, Barca ML, Eldholm RS, et al
    The Association Between Circulating Inflammatory Markers and the Progression of Alzheimer Disease in Norwegian Memory Clinic Patients With Mild Cognitive Impairment or Dementia.
    Alzheimer Dis Assoc Disord. 2019 Aug 13. doi: 10.1097/WAD.0000000000000342.
    PubMed     Abstract available


    July 2019
  40. SALCEDO-TACUMA D, Melgarejo JD, Mahecha MF, Ortega-Rojas J, et al
    Differential Methylation Levels in CpGs of the BIN1 Gene in Individuals With Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2019 Jul 19. doi: 10.1097/WAD.0000000000000329.
    PubMed     Abstract available


  41. CIPOLLINI V, Sette G, Bossu P, Ciaramella A, et al
    Neurovascular Dysfunction in Alzheimer Disease: Assessment of Cerebral Vasoreactivity by Ultrasound Techniques and Evaluation of Circulating Progenitor Cells and Inflammatory Markers.
    Alzheimer Dis Assoc Disord. 2019 Jul 19. doi: 10.1097/WAD.0000000000000331.
    PubMed     Abstract available


  42. THOMAS KR, Bangen KJ, Weigand AJ, Edmonds EC, et al
    Type II Diabetes Interacts With Alzheimer Disease Risk Factors to Predict Functional Decline.
    Alzheimer Dis Assoc Disord. 2019 Jul 10. doi: 10.1097/WAD.0000000000000332.
    PubMed     Abstract available


    May 2019
  43. AKUZAWA N, Yoshii A, Ono A, Kuwako T, et al
    Predictors of Discontinuance of Oral Feeding in Patients With Advanced Alzheimer Dementia and Aspiration Pneumonia in Japan: A Single-center, Retrospective Observational Study.
    Alzheimer Dis Assoc Disord. 2019 May 24. doi: 10.1097/WAD.0000000000000316.
    PubMed     Abstract available


  44. HATA K, Nakamoto K, Nunomura A, Sone D, et al
    Automated Volumetry of Medial Temporal Lobe Subregions in Mild Cognitive Impairment and Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2019 May 22. doi: 10.1097/WAD.0000000000000318.
    PubMed     Abstract available


  45. TAKEDA A, Sturm VE, Rankin KP, Ketelle R, et al
    Relationship Turmoil and Emotional Empathy in Frontotemporal Dementia.
    Alzheimer Dis Assoc Disord. 2019 May 22. doi: 10.1097/WAD.0000000000000317.
    PubMed     Abstract available


  46. FAN J, Tse M, Carr JS, Miller BL, et al
    Alzheimer Disease-associated Cortical Atrophy Does not Differ Between Chinese and Whites.
    Alzheimer Dis Assoc Disord. 2019 May 13. doi: 10.1097/WAD.0000000000000315.
    PubMed     Abstract available


  47. GLOVER CM, CoCroft S, James BD, Barnes LL, et al
    Perceptions of Risk Factors for Alzheimer Disease Among Community-Dwelling, Nondemented Older African Americans.
    Alzheimer Dis Assoc Disord. 2019 May 1. doi: 10.1097/WAD.0000000000000314.
    PubMed     Abstract available


    April 2019
  48. CAI M, Guo Z, Xing G, Peng H, et al
    Transcranial Direct Current Stimulation Improves Cognitive Function in Mild to Moderate Alzheimer Disease: A Meta-Analysis.
    Alzheimer Dis Assoc Disord. 2019 Apr 24. doi: 10.1097/WAD.0000000000000304.
    PubMed     Abstract available


  49. GRILL JD, Nuno MM, Gillen DL
    Which MCI Patients Should be Included in Prodromal Alzheimer Disease Clinical Trials?
    Alzheimer Dis Assoc Disord. 2019 Apr 4. doi: 10.1097/WAD.0000000000000303.
    PubMed     Abstract available


    February 2019
  50. TAKESHIMA N, Ishiwata K, Sozu T, Furukawa TA, et al
    Primary Endpoints in Current Phase II/III Trials for Alzheimer Disease: A Systematic Survey of Trials Registered at ClinicalTrials.gov.
    Alzheimer Dis Assoc Disord. 2019 Feb 5. doi: 10.1097/WAD.0000000000000297.
    PubMed     Abstract available


    January 2019
  51. ANDREWS SJ, McFall GP, Dixon RA, Cherbuin N, et al
    Alzheimer's Environmental and Genetic Risk Scores are Differentially Associated With General Cognitive Ability and Dementia Severity.
    Alzheimer Dis Assoc Disord. 2019 Jan 23. doi: 10.1097/WAD.0000000000000292.
    PubMed     Abstract available


  52. SQUITTI R, Mendez A, Ricordi C, Siotto M, et al
    Copper in Glucose Intolerance, Cognitive Decline, and Alzheimer's Disease.
    Alzheimer Dis Assoc Disord. 2019 Jan 10. doi: 10.1097/WAD.0000000000000280.
    PubMed     Abstract available


  53. BREGMAN N, Kave G, Mirelman A, Thaler A, et al
    Distinguishing Dementia With Lewy Bodies From Alzheimer's Disease: What is the Influence of the GBA Genotype in Ashkenazi Jews?
    Alzheimer Dis Assoc Disord. 2019 Jan 10. doi: 10.1097/WAD.0000000000000283.
    PubMed     Abstract available


  54. PERINI G, Cotta Ramusino M, Sinforiani E, Franciotta D, et al
    Role of Cerebrospinal Fluid Biomarkers and (18)F-florbetapir PET Imaging in the Diagnosis of Primary Progressive Aphasia: A Retrospective Analysis.
    Alzheimer Dis Assoc Disord. 2019 Jan 10. doi: 10.1097/WAD.0000000000000289.
    PubMed     Abstract available


  55. HAN JY, Besser LM, Xiong C, Kukull WA, et al
    Cholinesterase Inhibitors May Not Benefit Mild Cognitive Impairment and Mild Alzheimer Disease Dementia.
    Alzheimer Dis Assoc Disord. 2019 Jan 9. doi: 10.1097/WAD.0000000000000291.
    PubMed     Abstract available


  56. ALEXANDER J, Strobel T, Georgitsi M, Honigschnabl S, et al
    Neuropathology-driven Whole-genome Sequencing Study Points to Novel Candidate Genes for Healthy Brain Aging.
    Alzheimer Dis Assoc Disord. 2019;33:7-14.
    PubMed     Abstract available


    November 2018
  57. JAVAHERIAN K, Newman BM, Weng H, Hassenstab J, et al
    Examining the Complicated Relationship Between Depressive Symptoms and Cognitive Impairment in Preclinical Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2018 Nov 26. doi: 10.1097/WAD.0000000000000284.
    PubMed     Abstract available


    October 2018
  58. BESSER L, Kukull W, Knopman DS, Chui H, et al
    Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set.
    Alzheimer Dis Assoc Disord. 2018 Oct 29. doi: 10.1097/WAD.0000000000000279.
    PubMed     Abstract available


    September 2018
  59. ARBOLEDA-BUSTOS CE, Ortega-Rojas J, Mahecha MF, Arboleda G, et al
    The p.R47H Variant of TREM2 Gene is Associated With Late-onset Alzheimer Disease in Colombian Population.
    Alzheimer Dis Assoc Disord. 2018 Sep 14. doi: 10.1097/WAD.0000000000000275.
    PubMed     Abstract available


  60. GAGLIARDI S, Davin A, Bini P, Sinforiani E, et al
    A Novel Nonsense Angiogenin Mutation is Associated With Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2018 Sep 4. doi: 10.1097/WAD.0000000000000272.
    PubMed    


    August 2018
  61. WELLS JL, Pasternak SH
    Case Report of a 63-Year-Old Patient With Alzheimer Disease and a Novel Presenilin 2 Mutation.
    Alzheimer Dis Assoc Disord. 2018 Aug 16. doi: 10.1097/WAD.0000000000000269.
    PubMed    


  62. KNAPSKOG AB, Braekhus A, Engedal K
    The Effect of Changing the Amyloid beta42 Cut-off of Cerebrospinal Fluid Biomarkers on Alzheimer Disease Diagnosis in a Memory Clinic Population in Norway.
    Alzheimer Dis Assoc Disord. 2018 Aug 13. doi: 10.1097/WAD.0000000000000268.
    PubMed    


    July 2018
  63. JIA X, Shi L, Qian T, Li Y, et al
    Improved Gray Matter Atrophy Detection in Alzheimer Disease in Chinese Populations Using Chinese Brain Template.
    Alzheimer Dis Assoc Disord. 2018 Jul 17. doi: 10.1097/WAD.0000000000000264.
    PubMed     Abstract available


    June 2018
  64. BARBER JM, Bardach SH, Jicha GA
    Alzheimer Disease Clinical Trial Recruitment: Does Participation in a Brief Cognitive Screen at a Community Health Fair Promote Research Engagement?
    Alzheimer Dis Assoc Disord. 2018 Jun 25. doi: 10.1097/WAD.0000000000000263.
    PubMed     Abstract available


  65. STITES SD, Harkins K, Rubright JD, Karlawish J, et al
    Relationships Between Cognitive Complaints and Quality of Life in Older Adults With Mild Cognitive Impairment, Mild Alzheimer Disease Dementia, and Normal Cognition.
    Alzheimer Dis Assoc Disord. 2018 Jun 25. doi: 10.1097/WAD.0000000000000262.
    PubMed     Abstract available


    May 2018
  66. GROSSBERG GT, Alva G, Hendrix S, Ellison N, et al
    Memantine ER Maintains Patient Response in Moderate to Severe Alzheimer's Disease: Post Hoc Analyses From a Randomized, Controlled, Clinical Trial of Patients Treated With Cholinesterase Inhibitors.
    Alzheimer Dis Assoc Disord. 2018 May 16. doi: 10.1097/WAD.0000000000000261.
    PubMed     Abstract available


  67. BAHIA VS, Cecchini MA, Cassimiro L, Viana R, et al
    The Accuracy of INECO Frontal Screening in the Diagnosis of Executive Dysfunction in Frontotemporal Dementia and Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2018 May 4. doi: 10.1097/WAD.0000000000000255.
    PubMed     Abstract available


    April 2018
  68. PIERCE AL, Cox CG, Nguyen H, Hoang D, et al
    Participant Satisfaction With Learning Alzheimer Disease Clinical Trial Results.
    Alzheimer Dis Assoc Disord. 2018 Apr 20. doi: 10.1097/WAD.0000000000000258.
    PubMed    


    March 2018
  69. ALLISON S, Babulal GM, Stout SH, Barco PP, et al
    Alzheimer Disease Biomarkers and Driving in Clinically Normal Older Adults: Role of Spatial Navigation Abilities.
    Alzheimer Dis Assoc Disord. 2018 Mar 23. doi: 10.1097/WAD.0000000000000257.
    PubMed     Abstract available


  70. BRADFIELD NI, Ellis KA, Savage G, Maruff P, et al
    Baseline Amnestic Severity Predicts Progression From Amnestic Mild Cognitive Impairment to Alzheimer Disease Dementia at 3 Years.
    Alzheimer Dis Assoc Disord. 2018 Mar 20. doi: 10.1097/WAD.0000000000000252.
    PubMed     Abstract available


  71. LADEIRA F, Cacao G, Correia AP, Pinto PS, et al
    When Decrease Abeta1-42 in CSF May Not Mean Alzheimer's Disease: Insights From Two Case Reports With Early Onset Dementia.
    Alzheimer Dis Assoc Disord. 2018 Mar 9. doi: 10.1097/WAD.0000000000000248.
    PubMed    


    February 2018
  72. LIMA-SILVA TB, Bahia VS, Cecchini MA, Cassimiro L, et al
    Validity and Reliability of the Frontotemporal Dementia Rating Scale (FTD-FRS) for the Progression and Staging of Dementia in Brazilian Patients.
    Alzheimer Dis Assoc Disord. 2018 Feb 13. doi: 10.1097/WAD.0000000000000246.
    PubMed     Abstract available


    January 2018
  73. GABEL M, Gooblar J, Roe CM, Selsor NJ, et al
    Political Ideology, Confidence in Science, and Participation in Alzheimer Disease Research Studies.
    Alzheimer Dis Assoc Disord. 2018 Jan 18. doi: 10.1097/WAD.0000000000000244.
    PubMed     Abstract available


  74. MILAN-TOMAS A, Shapiro CM
    Circadian Rhythms Disturbances in Alzheimer Disease: Current Concepts, Diagnosis, and Management.
    Alzheimer Dis Assoc Disord. 2018 Jan 18. doi: 10.1097/WAD.0000000000000243.
    PubMed     Abstract available


    December 2017
  75. SOUSA MFB, Santos RL, Simoes P, Conde-Sala JL, et al
    Discrepancies Between Alzheimer's Disease Patients' and Caregivers' Ratings About Patients' Quality of Life: A 1-year Observation Study in Brazil.
    Alzheimer Dis Assoc Disord. 2017 Dec 27. doi: 10.1097/WAD.0000000000000232.
    PubMed     Abstract available


  76. WEINTRAUB S, Besser L, Dodge HH, Teylan M, et al
    Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set (UDS).
    Alzheimer Dis Assoc Disord. 2017 Dec 13. doi: 10.1097/WAD.0000000000000223.
    PubMed     Abstract available


    November 2017
  77. TENSIL M, Hessler JB, Gutsmiedl M, Riedl L, et al
    Sex Differences in Neuropsychological Test Performance in Alzheimer's Disease and the Influence of the ApoE Genotype.
    Alzheimer Dis Assoc Disord. 2017 Nov 17. doi: 10.1097/WAD.0000000000000229.
    PubMed     Abstract available


    October 2017
  78. LACERDA IB, Santos RL, Neto JPS, Dourado MCN, et al
    Factors Related to Different Objects of Awareness in Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2017;31:335-342.
    PubMed     Abstract available


    September 2017
  79. MOULDER KL, Besser LM, Beekly D, Blennow K, et al
    Factors Influencing Successful Lumbar Puncture in Alzheimer Research.
    Alzheimer Dis Assoc Disord. 2017 Sep 7. doi: 10.1097/WAD.0000000000000209.
    PubMed     Abstract available


    August 2017
  80. PANEGYRES PK, Goh J, McCarthy M, Campbell AI, et al
    The Nature and Natural History of Posterior Cortical Atrophy Syndrome: A Variant of Early-onset Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2017 Aug 8. doi: 10.1097/WAD.0000000000000207.
    PubMed     Abstract available


  81. ZADORI D, Fuvesi J, Timar E, Horvath E, et al
    The Report of p.Val717Phe Mutation in the APP Gene in a Hungarian Family With Alzheimer Disease: A Phenomenological Study.
    Alzheimer Dis Assoc Disord. 2017 Aug 8. doi: 10.1097/WAD.0000000000000206.
    PubMed    


    June 2017
  82. STONNINGTON CM, Harel B, Locke DEC, Hentz JG, et al
    Lorazepam Challenge for Individuals at Varying Genetic Risk for Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2017 Jun 2. doi: 10.1097/WAD.0000000000000200.
    PubMed     Abstract available


    May 2017
  83. AZAR M, Zhu C, DeFeis B, Gu Y, et al
    Increased Reporting Accuracy of Alzheimer Disease Symptoms in Caribbean Hispanic Informants.
    Alzheimer Dis Assoc Disord. 2017 May 26. doi: 10.1097/WAD.0000000000000199.
    PubMed     Abstract available


  84. MICHAUD TL, High R, Charlton ME, Murman DL, et al
    Dependence Stage and Pharmacoeconomic Outcomes in Patients With Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2017 May 8. doi: 10.1097/WAD.0000000000000198.
    PubMed     Abstract available


    April 2017
  85. DAY GS, Gordon BA, Jackson K, Christensen JJ, et al
    Tau-PET Binding Distinguishes Patients With Early-stage Posterior Cortical Atrophy From Amnestic Alzheimer Disease Dementia.
    Alzheimer Dis Assoc Disord. 2017 Apr 7. doi: 10.1097/WAD.0000000000000196.
    PubMed     Abstract available


  86. KOENIG AM, Mechanic-Hamilton D, Xie SX, Combs MF, et al
    Effects of the Insulin Sensitizer Metformin in Alzheimer Disease: Pilot Data From a Randomized Placebo-controlled Crossover Study.
    Alzheimer Dis Assoc Disord. 2017;31:107-113.
    PubMed     Abstract available


    March 2017
  87. MORENO DJ, Pino S, Rios A, Lopera F, et al
    Genetic Ancestry and Susceptibility to Late-Onset Alzheimer's Disease (LOAD) in the Admixed Colombian Population.
    Alzheimer Dis Assoc Disord. 2017 Mar 31. doi: 10.1097/WAD.0000000000000195.
    PubMed     Abstract available


  88. OPOKU ST, Apenteng BA, Lin G
    Temporal Trends and Rural-Urban Differences in Hospital Length of Stay for Alzheimer Disease and Related Disorders.
    Alzheimer Dis Assoc Disord. 2017 Mar 14. doi: 10.1097/WAD.0000000000000183.
    PubMed     Abstract available


    January 2017
  89. VELAYOS-BAEZA A, Danek A
    Chorein Deficiency and Alzheimer Disease: An Intriguing, Yet Premature Speculation.
    Alzheimer Dis Assoc Disord. 2017 Jan 24. doi: 10.1097/WAD.0000000000000186.
    PubMed    


  90. LAZARCZYK MJ, Haller S, Savioz A, Gimelli S, et al
    Heterozygous Deletion of Chorein Exons 70-73 and GNA14 Exons 3-7 in a Brazilian Patient Presenting With Probable Tau-Negative Early-Onset Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2017 Jan 10. doi: 10.1097/WAD.0000000000000185.
    PubMed    


    December 2016
  91. PARK SA, Chae WS, Kim HJ, Shin HS, et al
    Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease in South Korea.
    Alzheimer Dis Assoc Disord. 2016 Dec 23. doi: 10.1097/WAD.0000000000000184.
    PubMed     Abstract available


  92. RITTER AR, Leger GC, Miller JB, Banks SJ, et al
    Neuropsychological Testing in Pathologically Verified Alzheimer Disease and Frontotemporal Dementia: How Well Do the Uniform Data Set Measures Differentiate Between Diseases?
    Alzheimer Dis Assoc Disord. 2016 Dec 21. doi: 10.1097/WAD.0000000000000181.
    PubMed     Abstract available


    November 2016
  93. TREBBASTONI A, Marcelli M, Mallone F, D'Antonio F, et al
    Attenuation of Choroidal Thickness in Patients With Alzheimer Disease: Evidence From an Italian Prospective Study.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Abstract available


  94. SUGIMOTO T, Ono R, Murata S, Saji N, et al
    Sarcopenia is Associated With Impairment of Activities of Daily Living in Japanese Patients With Early-Stage Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed    


  95. MONSELL SE, Mock C, Fardo DW, Bertelsen S, et al
    Genetic Comparison of Symptomatic and Asymptomatic Persons With Alzheimer Disease Neuropathology.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Abstract available


  96. DEVANAND DP, Pelton GH, D'Antonio K, Strickler JG, et al
    Low-dose Lithium Treatment for Agitation and Psychosis in Alzheimer Disease and Frontotemporal Dementia: A Case Series.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed    


  97. VERHULSDONK S, Lange-Asschenfeldt C, Hoft B, Schwender H, et al
    Repressive Coping Does Not Contribute to Anosognosia in First-Diagnosis Patients With Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Abstract available


  98. DE LUCIA N, Grossi D, Trojano L
    Closing-in is Related to Daily Living Functioning in Patients With Mild-to-Moderate Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed    


    October 2016
  99. PRUZIN JJ, Schneider JA, Capuano AW, Leurgans SE, et al
    Diabetes, Hemoglobin A1C, and Regional Alzheimer Disease and Infarct Pathology.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Abstract available


  100. ZUCCHELLA C, Bartolo M, Bernini S, Picascia M, et al
    Modeling Alzheimer's Disease Through Functional Independence and Participation.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Abstract available


    September 2016
  101. LAGARDE J, Sarazin M, Chauvire V, Stankoff B, et al
    Cholinergic Changes in Aging and Alzheimer Disease: An [18F]-F-A-85380 Exploratory PET Study.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Abstract available


    January 2016
  102. GERSTENECKER A, Triebel KL, Martin R, Snyder S, et al
    Both Financial and Cognitive Decline Predict Clinical Progression in MCI.
    Alzheimer Dis Assoc Disord. 2016;30:27-34.
    PubMed     Abstract available


  103. WALTER S, Marden JR, Kubzansky LD, Mayeda ER, et al
    Diabetic Phenotypes and Late-Life Dementia Risk: A Mechanism-specific Mendelian Randomization Study.
    Alzheimer Dis Assoc Disord. 2016;30:15-20.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: